Drug Type Fusion protein |
Synonyms TIGIT x OX40L (Agonist Redirected Checkpoint)(Shattuck Labs), dual TIGIT checkpoint inhibitor/OX40 costimulator (Shattuck Labs) |
Target |
Mechanism OX40 agonists(Tumor necrosis factor receptor superfamily member 4 agonists), PVR inhibitors(CD155 Antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 09 Nov 2019 |